Cargando…
The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview
Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC), which are characterized by chronic inflammation of the gastrointestinal (GI) tract. IBDs clinical manifestations are heterogeneous and characterized by a chronic relapsing-remitting course. Typical gastrointe...
Autores principales: | Amodeo, Giada, Franchi, Silvia, Galimberti, Giulia, Riboldi, Benedetta, Sacerdote, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669895/ https://www.ncbi.nlm.nih.gov/pubmed/38001985 http://dx.doi.org/10.3390/biomedicines11112985 |
Ejemplares similares
-
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model
por: Galimberti, Giulia, et al.
Publicado: (2023) -
The Antagonism of the Prokineticin System Counteracts Bortezomib Induced Side Effects: Focus on Mood Alterations
por: Amodeo, Giada, et al.
Publicado: (2021) -
Interplay between Prokineticins and Histone Demethylase KDM6A in a Murine Model of Bortezomib-Induced Neuropathy
por: Rullo, Laura, et al.
Publicado: (2021) -
Prokineticin Receptor Inhibition With PC1 Protects Mouse Primary Sensory Neurons From Neurotoxic Effects of Chemotherapeutic Drugs in vitro
por: Moschetti, Giorgia, et al.
Publicado: (2020) -
Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes
por: Castelli, Mara, et al.
Publicado: (2016)